A novel islet cell therapy delivered through a single infusion lowered HbA1c and eliminated severe hypoglycemia events for ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Dr. Rahul Baxi highlights that a new Rs 16,000-a-month weight-loss injection isn't a miracle solution without essential ...

Lifestyle choices such as physical activity levels and overall diet quality have more impact on diabetes risk than sugar ...

A new study adds to evidence to suggest the main ingredient in Novo Nordisk’s injectable drug for type 2 diabetes may ...

In patients with diabetes, semaglutide use was associated with an increased risk for nonarteritic anterior ischemic optic ...

Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...

There’s no question about the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, but some doctors are worried the ...

Reviewed by Dietitian Kelli McGrane If you have type 2 diabetes, you have likely been told that weight loss may help improve ...

Patients with diabetes who take semaglutide are at increased risk for NAION compared with patients who do not use GLP-1 RAs to control their blood sugar, a new study finds.

In the bowl you used for the sweet potato and carrots, add the broccoli, red pepper, and chicken. Add the remaining 2 tbsp ...

Price of several essential medicines will reportedly increase from 1 April. The list of medicines set to get costlier reportedly includes the one used to manage health conditions like diabetese, heart ...